Pages that link to "Q34419540"

The following pages link to Functional heavy-chain antibodies in Camelidae (Q34419540):

Displaying 48 items.

• The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi (Q24800574) (← links)
• Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains (Q27678732) (← links)
• Affinity is an important determinant of the anti-trypanosome activity of nanobodies (Q28485195) (← links)
• Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm (Q31007389) (← links)
• Molecular imprint of enzyme active site by camel nanobodies: rapid and efficient approach to produce abzymes with alliinase activity (Q31049237) (← links)
• Isolation of monomeric human V(H)s by a phage selection (Q33225080) (← links)
• Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains (Q33270541) (← links)
• Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs). (Q33287667) (← links)
• A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy. (Q33467203) (← links)
• Determination of Aspergillus pathogens in agricultural products by a specific nanobody-polyclonal antibody sandwich ELISA. (Q33849070) (← links)
• A novel VHH antibody targeting the B cell-activating factor for B-cell lymphoma (Q33907508) (← links)
• Emergence and evolution of functional heavy-chain antibodies in Camelidae (Q33963905) (← links)
• Fingerprint-like Analysis of "Nanoantibody" Selection by Phage Display Using Two Helper Phage Variants (Q34287684) (← links)
• Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies (Q34574853) (← links)
• Generation of heavy-chain-only antibodies in mice (Q35062276) (← links)
• Functional inhibition of β-catenin-mediated Wnt signaling by intracellular VHH antibodies (Q35530296) (← links)
• Camelid nanobodies with high affinity for broad bean mottle virus: a possible promising tool to immunomodulate plant resistance against viruses (Q35554586) (← links)
• Phage display selection of tight specific binding variants from a hyperthermostable Sso7d scaffold protein library (Q35911849) (← links)
• Opinion: antibody-based therapies for malaria (Q36302325) (← links)
• Natural and man-made V-gene repertoires for antibody discovery. (Q36401413) (← links)
• Nanobody(R)-based chromatin immunoprecipitation/micro-array analysis for genome-wide identification of transcription factor DNA binding sites (Q36684736) (← links)
• Prodrugs for the treatment of neglected diseases. (Q37157236) (← links)
• Nanobodies as novel agents for disease diagnosis and therapy. (Q38160835) (← links)
• Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer (Q38230884) (← links)
• Purification and quantification of heavy-chain antibodies from the milk of bactrian camels (Q38759949) (← links)
• Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier (Q38929360) (← links)
• Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line. (Q39229818) (← links)
• Anti-erythrocyte natural antibody activity in the unconventional 'heavy chain' immunoglobulins of Indian desert camel (Camelus dromedarius). (Q39444077) (← links)
• SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression (Q40009259) (← links)
• Alternative reagents to antibodies in imaging applications (Q41579389) (← links)
• Application of monoclonal antibodies in functional and comparative investigations of heavy-chain immunoglobulins in new world camelids (Q41790708) (← links)
• Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function (Q41861205) (← links)
• Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting (Q41875163) (← links)
• Generation of diversity by somatic mutation in the Camelus dromedarius T-cell receptor gamma variable domains. (Q44668250) (← links)
• Camelid immunoglobulins and nanobody technology. (Q47221693) (← links)
• Reporter-nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents. (Q50026240) (← links)
• Silencing of the immunoglobulin heavy chain locus by removal of all eight constant-region genes in a 200-kb region. (Q52086792) (← links)
• Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice (Q57492008) (← links)
• The Production and Characterization of Novel Heavy-Chain Antibodies Against the Tandem Repeat Region of MUC1 Mucin (Q57567888) (← links)
• Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor (Q57692156) (← links)
• Strongin VivoMaturation Compensates for Structurally Restricted H3 Loops in Antibody Repertoires (Q57985824) (← links)
• Heavy-chain only antibodies derived from dromedary are secreted and displayed by mouse B cells (Q57985835) (← links)
• Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases (Q58590838) (← links)
• An improved yeast surface display platform for the screening of nanobody immune libraries (Q61445154) (← links)
• Immunobiological role of llama heavy-chain antibodies against a bacterial beta-lactamase (Q80192510) (← links)
• Development of ELISAs for the measurement of IgM and IgG subclasses in sera from llamas (Lama glama) and assessment of the humoral immune response against different antigens (Q81765455) (← links)
• A new approach to study cellular components associated with a certain protein (Q82291569) (← links)
• VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis (Q92559131) (← links)